https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Received-European-Commission-Approval-for-SKYCLARYS-omaveloxolone-the-First-Therapy-to-T-45934739/?utm_source=telegram&utm_medium=social&utm_campaign=share